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Superselective bronchial embolization is recently performed with a high success rate. 
The current study aimed at discussing the procedure and reporting two cases 
underwent embolization in the Masih-Daneshvari Hospital, a large center for this 
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INTRODUCTION
Bronchial arteries embolization (BAE) is mainly 
performed in moderate to severe hemoptysis cases 
irresponsive to medical managements [1]. This 
procedure remains a palliative procedure for 
management of hemoptysis in patients who are not 
candidate for more invasive treatments such as surgery. 
Most common reported underlying diseases are 
tuberculosis (TB), bronchiectasis, and aspergillomas 
[1]. Short-term success and immediate bleeding 
cessation were high; however, recurrence may occur. 
Recurrence may be due to incomplete embolization, 
recanalization of previously embolized vessels, and 
recruitment of new collaterals due to main disease 
progression. Presence of non-bronchial systemic 
collaterals, abnormal site of collaterals (e g, coronary 
arteries), bronchopulmonary shunting, aspergillomas 
reactivation, and multidrug resistant TB are associated 
with higher recurrence rates. After 2010, most published 
reports emphasized superselective embolization to 
decrease procedural complications and administration 
of polyvinyl alcohol (PVA) in lower doses [1]. 
The initial control rate of hemoptysis was reported 96% 
(21 of 22) in a study on a superselective group and 88% 
(22 of 25) in the non-superselective group. Cumulative 
hemoptysis control rates of the super-selective and non-
superselective groups were 80% and 67% at six months, 
79% and 56% at one and two years, and 79% and 48% at 
three years, respectively; although the difference was 
insignificant using the generalized Wilcoxon test. One 
major complication (spinal infarction) occurred in the 
non-superselective group [2]. Superselective 
embolization enabled bypassing spinal arteries and 
abolished smaller and more distal and torturous arteries, 
which led to better control of hemoptysis and lower risk 
of complications.  
CASE PRESENTATION 
Here is the report of two successful cases of rare 
superselective BAE. The first case was a 34-year-old 
male with the history of bronchiectasis presented with 
massive hemoptysis. Based on chest computed 
tomography (CT) scan images, bleeding source was in 
the right side. The patient was scheduled for the 
embolization of bronchial arteries originated from 
thoracic region. The procedure was performed with 
PVA successfully with no complications. Seven days 
later, the patient returned and this time CT scan images 
showed the left sided bleeding. 
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Figure 1. Superselective embolization in a branch artery 
originating from left internal mammary artery 
 
Then the patient underwent angiography and the target 
vessels were detected as some branches originating from 
left internal mammary artery (Fig 1). Selective 
embolization was performed on the determined vessels. 
For this propose, a 6F guide catheter was inserted. A 
0.014-inch hydrophilic guidewire (pilot 50 Abbott 
Vascular, Ltd.) was passed through the tortuous vessel 
with a 2.7-Fr. microcatheter (Rebar 18, Ev3 Co.).  
 
 
Figure 2. Superselective embolization in a branch artery 
originating from right internal mammary artery 
 
Two milliliters of PVA 700 was injected via the 
microcatheter into the target vessels. The patient was 
admitted to the intensive care unit and discharged after 
two days with no hemoptysis. Three months follow-up 
showed no sign of bleeding recurrence. 
In the second case, a 32-year-old male patient with 
chronic thromboembolic pulmonary hypertension, 
aberrant bronchial vessel originated from right internal 
mammary artery (Fig 2). After embolizing the thoracic 
branches, superselective embolization was performed 
on the aberrant vessel using the aforementioned 
technique. Both procedures were performed with the 
injection of 3000 units of intravenous heparin, BiPAP 
oxygen mask to perform O2 saturation > 90%, and 6-Fr 
right transfemoral artery sheath size. 
CONCLUSIONS 
In patients with hemoptysis, BAE can be a curative 
procedure after medical treatment or may be a bridge 
therapy before surgery for stabilizing the patient’s 
conditions and postponing the surgery until the 
stabilization of patient’s conditions. Although surgery is 
a definitive therapy, it carries a mortality of 18% when 
performed electively, which can increase to 40% when 
performed emergently [3]. Bronchial embolization is a 
minimally invasive procedure, which can be performed 
in critically ill patients. 
Angiographically, the bronchial arteries arise from the 
descending thoracic aorta between the upper t5 and the 
lower t6 vertebral bodies in 70% of the normal 
population. Another 10% remain a first order branch of 
the thoracic aorta or arch, but outside of the t5-t6. The 
remaining 20% originate from a variety of structures 
including the thoracic (brachiocephalic, subclavian, 
internal mammary, pericardiopherenic, or 
thyrocervical) and abdominal (aorta, inferior phrenic or 
celiac) branches [4-6]. 
Non-bronchia collaterals should be assessed and treated 
concurrently with the bronchial arteries at the time of 
initial arteriogram. In the two reported cases, two non-
bronchial collaterals were successfully embolized 
following the embolization of bronchial arteries. 
Likewise, the application of microcatheter in a coaxial 
technique is now well documented for selective 
catheterization and administration of embolic agents [7, 
8]. Technical success rate is reported 90% [9]. 
Amongst articles published before 2010, superselective 
embolization was notably reported in four studies [10]. 
In the current study center, the success rate of bronchial 
embolization was about 92% and complication rate 
10%. Right bronchial arteries are the most common 
bronchials embolized in previous reports, while non-
bronchial systemic collaterals were embolized in the first 
session in about 40%-62% of patients in different reports 
[11]. 
The intercostal and internal mammary arteries were the 
most frequently embolized non-bronchial systemic 
collaterals [11]. 
Ramakantan et al., recommended not to embolize non-
bronchial systemic collaterals in the first session [12]. 
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Although it is a safe procedure, the search for non-
bronchial arteries reduces the recurrence rate [13]. 
In the current study center, the non-bronchial arteries 
were routinely examined in the same session, which 
helped us with the better control of hemoptysis. For the 
non-bronchial arteries, superselective embolization is 
preferred due to lower complications and better 
outcomes. In other bronchials, superselective 
embolization did not perform routinely and our findings 
were similar to those of other studies. The non-
superselective embolization is easy to perform and cost-
effective. However, the shorter duration and less 
contrast injection are the other advantages of the 
procedure.  
Neurologic complications due to spinal cord ischemia 
leading to transient or permanent paraparesis or 
paraplegia occur in 0.6%–4.4% of the cases [14-16]. It is 
mostly attributed to inadvertent embolization of spinal 
arteries arising from bronchial or intercostobronchial 
arteries. However, in two studies with the incidence of 
paraparesis, spinal arteries were not visualized even on 
retrospective review of the digital subtraction 
angiography images. Although some authors considered 
visualization of anterior spinal artery as a 
contraindication for BAE [14-16], superselective 
catheterization enabled safer embolization in most 
studies. 
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